79 related articles for article (PubMed ID: 17977418)
1. [Treatment of non-Hodgkin's lymphomas of medium and high malignancy].
Mihaljević B; Petrović M; Jancić-Nedeljkov R; Jovanović V; Rolović Z
Srp Arh Celok Lek; 1994; 122(5-6):164-8. PubMed ID: 17977418
[TBL] [Abstract][Full Text] [Related]
2. [Effect of polychemotherapy in the treatment of patients with non-Hodgkin's lymphoma].
Belić A; Popović S; Savić I
Med Pregl; 1992; 45(5-6):188-93. PubMed ID: 1365055
[TBL] [Abstract][Full Text] [Related]
3. [Integrative concept on the treatment of highly malignant non-Hodgkin lymphomas].
Havemann K; Köppler H; Kaiser U; Pfreundschuh M
Praxis (Bern 1994); 1996 Mar; 85(12):353-6. PubMed ID: 8643897
[TBL] [Abstract][Full Text] [Related]
4. [Use of dexamethasone in treatment of high- and low-grade non-Hodgkin's lymphoma].
Alekseeva IuA; Zaritskiĭ AIu; Medvedeva NV; Mikhaĭlova NB; Zubarovskaia LS; Afanas'ev BV
Vopr Onkol; 2004; 50(6):726-8. PubMed ID: 15755073
[TBL] [Abstract][Full Text] [Related]
5. [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].
Li QC; Yuan XL; Wang YF; Zou DH; Zhao YZ; Qiu LG
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):254-7. PubMed ID: 18361837
[TBL] [Abstract][Full Text] [Related]
6. Primary gastric lymphoma. A survey of 7 cases.
Jarczok K; Luciak M; Kardaszewicz S; Huzarski J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):604-9. PubMed ID: 2448198
[TBL] [Abstract][Full Text] [Related]
7. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
8. [Activity of natural cytotoxic cells in non-Hodgkin's lymphoma].
Frydecka I; Kotlarek-Haus S; Kuliczkowski K; Kuliszkiewicz-Janus M
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):357-9. PubMed ID: 1437753
[TBL] [Abstract][Full Text] [Related]
9. Use of rituximab in combination with conventional chemotherapy for the treatment of non-Hodgkin's lymphoma of the head and neck.
Manolopoulos L; Gomatos IP; Leandros E; Alevizos L; Georgiou N; Giotakis J; Ferekidis E
In Vivo; 2009; 23(3):475-8. PubMed ID: 19454517
[TBL] [Abstract][Full Text] [Related]
10. [Non-Hodgkin's primitive lymphoma of the testis: long-term prognosis associated with treatment combining systemic and intrathecal chemotherapy].
Sénéchal C; Saint F; Petit T; Petit J
Prog Urol; 2009 Mar; 19(3):209-14. PubMed ID: 19268261
[TBL] [Abstract][Full Text] [Related]
11. Treatment of low grade and intermediate grade non-Hodgkin's lymphomas with intensive combination chemotherapy.
Bolaman Z; Sentürk T; Kadköylü G
Haematologica; 1999; 84(E-letters):E03. PubMed ID: 11084661
[No Abstract] [Full Text] [Related]
12. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
13. Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Zwick C; Birkmann J; Peter N; Bodenstein H; Fuchs R; Hänel M; Reiser M; Hensel M; Clemens M; Zeynalova S; Ziepert M; Pfreundschuh M;
Ann Hematol; 2008 Sep; 87(9):717-26. PubMed ID: 18587579
[TBL] [Abstract][Full Text] [Related]
14. Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
Lazar AD; Shpilberg O; Shaklai M; Bairey O
Isr Med Assoc J; 2009 Jan; 11(1):16-22. PubMed ID: 19344007
[TBL] [Abstract][Full Text] [Related]
15. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
16. Salvage combination chemotherapy with cisplatinum, etoposide and bleomycin in refractory non-Hodgkin's lymphomas.
Comella P; Abate G; Di Finizio G; Fiore M; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1262-3. PubMed ID: 16312858
[No Abstract] [Full Text] [Related]
17. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
18. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.
Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P
Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094
[TBL] [Abstract][Full Text] [Related]
19. [Post-therapy surveillance in non-Hodgkin's lymphomas].
Fohrer C; Oprea C; Herbrecht R
Rev Prat; 2002 May; 52(9):986-90. PubMed ID: 12063766
[TBL] [Abstract][Full Text] [Related]
20. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma.
De Renzo A; Perna F; Persico M; Notaro R; Mainolfi C; de Sio I; Ciancia G; Picardi M; Del Vecchio L; Pane F; Rotoli B
Eur J Haematol; 2008 Jul; 81(1):51-7. PubMed ID: 18397390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
